Your browser doesn't support javascript.
loading
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
Karschnia, Philipp; Arrillaga-Romany, Isabel C; Eichler, April; Forst, Deborah A; Gerstner, Elizabeth; Jordan, Justin T; Ly, Ina; Plotkin, Scott R; Wang, Nancy; Martinez-Lage, Maria; Winter, Sebastian F; Tonn, Joerg-Christian; Rejeski, Kai; von Baumgarten, Louisa; Cahill, Daniel P; Nahed, Brian V; Shankar, Ganesh M; Abramson, Jeremy S; Barnes, Jeffrey A; El-Jawahri, Areej; Hochberg, Ephraim P; Johnson, P Connor; Soumerai, Jacob D; Takvorian, Ronald W; Chen, Yi-Bin; Frigault, Matthew J; Dietrich, Jorg.
Afiliação
  • Karschnia P; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Arrillaga-Romany IC; Department of Neurosurgery, Section for Neuro-Oncology, Ludwig-Maximilians-University, Munich, Germany.
  • Eichler A; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Forst DA; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Gerstner E; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Jordan JT; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Ly I; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Plotkin SR; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Wang N; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Martinez-Lage M; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Winter SF; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Tonn JC; Department of Pathology, Division of Neuropathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Rejeski K; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • von Baumgarten L; Department of Neurosurgery, Section for Neuro-Oncology, Ludwig-Maximilians-University, Munich, Germany.
  • Cahill DP; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Nahed BV; German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  • Shankar GM; Department of Medicine III, Section for Cellular Immunotherapy, Ludwig-Maximilians-University, Munich, Germany.
  • Abramson JS; Department of Neurosurgery, Section for Neuro-Oncology, Ludwig-Maximilians-University, Munich, Germany.
  • Barnes JA; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • El-Jawahri A; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Hochberg EP; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Johnson PC; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Soumerai JD; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Takvorian RW; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Chen YB; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Frigault MJ; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Dietrich J; Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Neuro Oncol ; 25(12): 2239-2249, 2023 12 08.
Article em En | MEDLINE | ID: mdl-37402650
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Síndromes Neurotóxicas / Receptores de Antígenos Quiméricos / Linfoma Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Síndromes Neurotóxicas / Receptores de Antígenos Quiméricos / Linfoma Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos